Anti-CD4 Therapeutic Antibody (Clenoliximab)
Recombinant chimeric (primate/human) antibody expressed in CHO binding to human CD4/p55. Clenoliximab is a monoclonal antibody against CD4. It acts as an immunomodulator and has been investigated for the treatment of rheumatoid arthritis. The drug is a chimeric antibody from Macaca irus and Homo sapiens.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-732 |
| Pricing | Inquiry |
| Host | primate |
| Target | CD4/p55 |
| Species Reactivity | Human |
| Type | IgG4 - lambda |
| Applications | IF, IP, Neut, FuncS, ELISA, FC, ICC, Inhib, Stim, IHC |
| Storage | Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C. |